November 30, 2022
A California federal judge has thrown out a proposed class action from a former U.S. military service member alleging F. Hoffmann-La Roche Inc. and its affiliates failed to warn the U.S. government that their anti-malarial drug could have permanent psychiatric side effects, finding that his claims are blocked by the laws of New Jersey, where Roche was based when he was prescribed the drug.